Excess healthcare resource utilization and costs for commercially insured patients with pulmonary arterial hypertension: A real‐world data analysis

Ähnliche Einträge

• Association of risk assessment at diagnosis with healthcare resource utilization and health‐related quality of life outcomes in pulmonary arterial hypertension
  von: Allan Lawrie, et al.
  Veröffentlicht: (2024)
• Structured evaluation of unclear dyspnea–An attempt to shorten the diagnostic delay in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
  von: Salaheldin Ahmed, et al.
  Veröffentlicht: (2024)
• Severe pulmonary hypertension due to combined pulmonary fibrosis and emphysema: another cause of death among smokers
  von: André Carramenha de Góes Hirano
  Veröffentlicht: (2017)
• The effects of oxygenation on acute vasodilator challenge in pulmonary arterial hypertension
  von: Matthew D. Rockstrom, et al.
  Veröffentlicht: (2024)
• Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension
  von: Tejaswini P. Reddy, et al.
  Veröffentlicht: (2024)